Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases
US7449570B2 · kind B2 · utility
2Cited by
1References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 21, 2005 |
| Grant date | Nov 11, 2008 |
| Priority date | — |
| Expiry date | Apr 13, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention encompasses nucleoside compounds, compositions comprising the compounds and methods for treating or preventing diseases associated with nonsense mutations of mRNA by administering these compounds or compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.